FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

37108911000001109: Buprenorphine 2mg / Naloxone 500microgram sublingual tablets sugar free (DE Pharmaceuticals) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 15-May 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
171661000001117 Buprenorphine 2mg / Naloxone 500microgram sublingual tablets sugar free (DE Pharmaceuticals) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
171671000001110 Buprenorphine 2mg / Naloxone 500microgram sublingual tablets sugar free (DE Pharmaceuticals) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Buprenorphine 2mg / Naloxone 500microgram sublingual tablets sugar free (DE Pharmaceuticals) Is a Buprenorphine 2mg / Naloxone 500microgram sublingual tablets sugar free true Inferred relationship Existential restriction modifier
Buprenorphine 2mg / Naloxone 500microgram sublingual tablets sugar free (DE Pharmaceuticals) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Buprenorphine 2mg / Naloxone 500microgram sublingual tablets sugar free (DE Pharmaceuticals) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Buprenorphine 2mg / Naloxone 500microgram sublingual tablets sugar free (DE Pharmaceuticals) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Buprenorphine 2mg / Naloxone 500microgram sublingual tablets sugar free (DE Pharmaceuticals) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 3 (CD No Register) true Inferred relationship Existential restriction modifier
Buprenorphine 2mg / Naloxone 500microgram sublingual tablets sugar free (DE Pharmaceuticals) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Naloxone false Inferred relationship Existential restriction modifier
Buprenorphine 2mg / Naloxone 500microgram sublingual tablets sugar free (DE Pharmaceuticals) Has specific active ingredient Buprenorphine hydrochloride true Inferred relationship Existential restriction modifier
Buprenorphine 2mg / Naloxone 500microgram sublingual tablets sugar free (DE Pharmaceuticals) Has specific active ingredient Naloxone hydrochloride dihydrate false Inferred relationship Existential restriction modifier
Buprenorphine 2mg / Naloxone 500microgram sublingual tablets sugar free (DE Pharmaceuticals) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Buprenorphine 2mg / Naloxone 500microgram sublingual tablets sugar free (DE Pharmaceuticals) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Buprenorphine true Inferred relationship Existential restriction modifier
Buprenorphine 2mg / Naloxone 500microgram sublingual tablets sugar free (DE Pharmaceuticals) Has dispensed dose form Conventional release sublingual tablet true Inferred relationship Existential restriction modifier
Buprenorphine 2mg / Naloxone 500microgram sublingual tablets sugar free (DE Pharmaceuticals) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Buprenorphine 2mg / Naloxone 500microgram sublingual tablets sugar free (DE Pharmaceuticals) Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Buprenorphine 2mg / Naloxone 500microgram sublingual tablets sugar free (DE Pharmaceuticals) Has specific active ingredient Naloxone hydrochloride dihydrate true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Buprenorphine 2mg / Naloxone 500microgram sublingual tablets sugar free (DE Pharmaceuticals) 28 tablet Has AMP True Buprenorphine 2mg / Naloxone 500microgram sublingual tablets sugar free (DE Pharmaceuticals) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start